Schlafen-8 (Slfn8) is a member of the Schlafen family of proteins, which harbor helicase domains and are induced by LPS and interferons. It has been reported that the Schlafen family are involved in various cellular functions, including proliferation, differentiation and regulation of virus replication. Slfn8 has been implicated in T-cell differentiation in the thymus. However, the roles of Slfn8 in the immune system remains unclear. In this study, we generated Slfn8 knockout mice (Slfn8 −/− ) and investigated the immunological role of Slfn8 using the T-cell-mediated autoimmune model experimental autoimmune encephalomyelitis (EAE). We found that the clinical score was reduced in Slfn8 −/− mice. IL-6 and IL-17A cytokine production, which are associated with EAE onset and progression, were decreased in the lymph nodes of Slfn8 −/− mice. Immune cell populations in Slfn8 −/− mice, including macrophages, neutrophils, T cells and B cells, did not reveal significant differences compared with wild-type mice. In vitro activation of Slfn8 −/− T cells in response to TCR stimulation also did not reveal significant differences. To confirm the involvement of non-hematopoietic cells, we isolated CD45 − CD31 + endothelial cells and CD45 − CD31 − gp38 + fibroblastic reticular cells by FACS sorting. We showed that the levels of IL-6 and Slfn8 mRNA in CD45 − CD31 + endothelial cells were increased after EAE induction. In contrast, the level of IL-6 mRNA after EAE induction was markedly decreased in CD31 + endothelial cells from Slfn8 −/− mice. These results indicate that Slfn8 may play a role in EAE by regulating inflammation in endothelial cells.
Introduction
Schlafen (Slfn)-8 is a member of the Slfn family, which were first reported as modulators of T-cell development and activation in the thymus (1) . There are 10 Slfn family members in mice, which are divided into three subgroups according to size and domains (1, 2) . Slfn family members have a highly conserved N-terminal (AAA) domain, which is involved in ATP/GTP binding, and are induced by LPS and interferons (1, 3, 4) . Slfn8 is classified as subgroup III, which are 58-68 kDa in size and harbor an RNA helicase-like domain (1) .
The functions of various Slfn family members have been reported previously. Slfn1 has been shown to control the cell cycle, regulating induction of Cyclin D1 (5, 6) . Slfn2 mutant mice are susceptible to both bacterial and viral infections, suggesting Slfn2 is involved in maintaining quiescence in both T cells and monocytes (7) . Slfn2 has also been reported as a negative regulator of the metastasis and growth of malignant cells (8) . Slfn3 is expressed on CD4 + CD25 + T cells and up-regulated following T-cell activation (9) . Although the expression of Slfn family members including Slfn8 is induced in response to LPS and interferons (IFN) in various cells (1, 3, 4) , the functions of the Slfn family remain unclear.
Slfn8 appears to be involved in T-cell development and growth. The proliferation of Slfn8 transgenic T cells in response to TCR ligation has been shown to be impaired (1) . However, the physiological function of Slfn8 in the immune system remains unclear.
In this study, we generated Slfn8 knockout mice and investigated the role of Slfn8 in the development of experimental autoimmune encephalomyelitis (EAE). EAE is an inflammatory disorder of the central nervous system (CNS) characterized by demyelination (10) and is widely used as an animal model of multiple sclerosis (11) . Several reports have demonstrated that T cells play an important role in the development of EAE (12) (13) (14) . Furthermore, multiple pro-inflammatory cytokines are also involved in the development of EAE. IL-17A and IFN-γ are pro-inflammatory mediators that are mainly secreted by CD4 + T cells and are associated with EAE (15, 16) . Proinflammatory cytokines such as IL-6 and IL-1β secreted by various cells are also involved in differentiation of T h 17 and the development of autoimmune disease (17) (18) (19) . These cytokines play a role in the activation of T cells and many other cells. We demonstrate that Slfn8 −/− mice are resistant to EAE and that the expression of pro-inflammatory mediators is severely reduced by deleting Slfn8 in EAE. However, dysfunction of Slfn8 −/− T cells, as well as other leukocytes, was not detected. We demonstrate that IL-6 expression by lymphatic endothelial cells (ECs) of Slfn8 −/− mice is markedly reduced. Therefore, Slfn8 may be involved in the immune system via the regulation of inflammation in ECs.
Methods

Mice
C57BL/6J mice were purchased from SLC (Shizuoka, Japan). Mice were housed in a temperature-and light-regulated room in an Specific Pathogen Free (SPF) facility and received food and water ad libitum. All studies received local ethics review board approval and were performed in accordance with the guidelines of the animal care and use committee of the Research Institute for Microbial Diseases at Osaka University.
Generation of Slfn8 -/-mice
The Slfn8 gene was amplified from genomic DNA extracted from mouse ES cells (GSI-I cell line) by PCR. The targeting vector was constructed by replacing a fragment encoding Slfn8 with a neomycin-resistance gene cassette (neo), and herpes simplex virus thymidine kinase (HSV-TK) was inserted into the genomic fragment for negative selection. After the targeting vector was transfected into ES cells, G418 and gancyclovir doubly resistant colonies were selected and screened by PCR; recombination was further confirmed by Southern blotting. These homologous recombined clones were microinjected into blastocysts derived from C57BL/6 mice and transferred to pseudo-pregnant females. Matings of chimeric male mice to C57BL/6 female mice resulted in transmission of the mutant allele to the germline. Resulting Slfn8 +/-mice were intercrossed to generate Slfn8 -/-mice. 
Induction of EAE and clinical evaluation
Isolation of mononuclear cells
Mice were killed and inguinal lymph nodes and spleens were removed. Single-cell suspensions were prepared by gently pressing and washing cells through a 40-μm nylon cell strainer. Mononuclear cells in the spinal cord were isolated using Percoll gradient centrifugation. The spinal cord was extracted and dissociated by washing through a 40-μm nylon cell strainer. The cells were then centrifuged through a 37:70% discontinuous Percoll gradient. Mononuclear cells at the 37:70% Percoll interface were collected.
Measurement of cytokine production in homogenized lymph nodes
Cells isolated from the spleens and lymph nodes of the immunized mice were seeded into 96-well plates (5 × 10 5 cells per well), and then cultured for 72 h with 20 µg ml −1 MOG 35-55 peptide or culture medium (RPMI 1640 medium supplemented with 10% FCS, 50 µM mercaptoethanol, 100 U ml −1 penicillin and 100 µg ml −1 streptomycin). Supernatants were collected at 72 h and assayed for IL-17A and IFN-γ by ELISA (R&D Systems, Minneapolis, MN, USA).
In vitro T-cell proliferation assay
T cells were prepared from the spleens of mice using a Pan T Cell Isolation Kit (Miltenyi Biotec, Bergisch Gladbach, Germany). T cells (2 × 10 5 cells per well) were seeded into 96-well plates pretreated with 10 μg ml −1 anti-mouse CD3 (αCD3) (BD Biosciences, San Jose, CA, USA) and were then cultured for 48 h with 0.5 μg ml −1 anti-mouse CD28 (αCD28) (BD Biosciences). Detection of BrdU incorporation was performed by ELISA (Cell Proliferation ELISA, BrdU, Roche Diagnostics, Mannheim, Germany) according to the manufacturer's instructions.
Preparation of peritoneal exudate cells
At day 3 after injection of 2 ml of 4% (w/v) thioglycollate medium (Sigma, St. Louis, MO, USA) i.p., peritoneal exudate cells (PECs) were isolated by washing with ice-cold HBSS as previously described (20) . PECs were seeded into 96-well plates with LPS (1 µg ml
). Supernatants were collected at 24 h. IL-6 and TNF-α were measured by ELISA (R&D Systems).
Flow cytometry and cell sorting
Antibodies for flow cytometry were purchased from commercial sources as follows: anti-F4/80 (BM8; BioLegend, San Diego, CA, USA); anti-Mac1 (M1/70; BioLegend); antiLy6C (AL-21; BioLegend); anti-Siglec-F (E50-2446; BD Biosciences); anti-CCR3 (J073E5; BioLegend); anti-CD3 (145-2C11; BioLegend); anti-CD4 (GK1.5; BioLegend); anti-CD8 (53-5.8; BioLegend); anti-CD44 (IM7; BioLegend); anti-CD62L (MEL-14; BioLegend); anti-49b (DX5; BioLegend); anti-CD45 (30-F11; BioLegend); anti-CD31 (MEC13.3; BioLegend); anti-gp38 (8.1.1; BioLegend). Cells were washed in ice-cold FACS buffer (0.5% BSA, 2 mM EDTA in PBS), then incubated with each antibody for 15 min on ice protected from light and washed twice with FACS buffer. Data were acquired on a Canto II flow cytometer and Aria III (BD, Franklin Lakes, NJ, USA) and analyzed using FlowJo (Tree Star Inc., Ashland, OR, USA).
Isolation of ECs and fibroblastic reticular cells
Mice were killed and inguinal lymph nodes were removed from the immunized mice. Single-cell suspensions were prepared as describe previously (21) . Briefly, lymph nodes were excised, minced and digested with dispase II, collagenase (Wako, Osaka, Japan), and type II collagenase (Worthington Biochemical Corp., Lakewood, NJ, USA) with continuous shaking at 37°C. The digested tissue was passed through 40-μm filters to yield single-cell suspensions. Cells were stained with FITC-conjugated anti-CD31, PE-conjugated antigp38 and Pacific blue-conjugated anti-CD45 and harvested by cell sorting (FACSAria III, Becton Dickinson).
Quantitative PCR analysis
Total RNA was isolated using an RNA purification kit (Roche Diagnostics) and reverse transcription performed with ReverTra Ace (Toyobo, Osaka, Japan) according to the manufacturer's instructions. Fluorescence from the TaqMan probe (TaqMan Gene Expression Assays; Applied Biosystems, Foster City, CA, USA) for il6 and Slfn8 was detected with a ViiA7 Real-Time PCR System (Applied Biosystems). The level of mRNA expression was normalized to the expression level of 18S RNA.
Generation of bone marrow chimeric mice
Hematopoietic stem cells from bone marrow (BM) cells were prepared from WT and Slfn8 −/− mice. These cells were suspended in PBS (-) and injected intravenously into lethally irradiated WT or Slfn8 −/− mice. After 6 weeks, the chimeric mice were immunized for the induction of EAE.
Statistical analysis
Unless otherwise indicated, data are presented as the means ± SD. The statistical significance of differences between groups was calculated using the two-tailed Student t-test. P values of 0.05 were considered to indicate statistical significance.
Results
Slfn8 deficiency attenuated MOG 35-55 -induced EAE
To examine the physiological role of Slfn8 in the immune system, we first induced EAE in WT and Slfn8 −/− mice by immunizing them with a MOG . Slfn8
−/− mice showed resistance to EAE development compared with WT mice (Fig. 1a) . Inflammatory cell infiltration into the CNS is a key feature of EAE development (11) . After EAE onset, the number of mononuclear cells in the spinal cord of Slfn8 −/− mice was reduced compared with WT mice (Fig. 1b) . These findings indicate that Slfn8 plays some role in the immune system in vivo.
Next, we investigated whether other Slfn family proteins were involved in the development of EAE using the appropriate knockout (KO) mice. We generated Schlafen-1 (Slfn1), Schlafen-3 (Slfn3) and Schlafen-5 (Slfn5) knockout mice and induced EAE in the same way as for Slfn8 −/− mice. The EAE clinical scores in the various Slfn family KO mice were comparable to the WT control mice (Fig. 2a-c) .
Inflammatory cytokine levels were reduced in Slfn8
−/− mice after EAE induction T h 17 and T h 1 cytokines are central regulators of EAE development (15, 16) . We analyzed the production of representative T h 1 and T h 17 cytokines, IFN-γ and IL-17A, in draining lymph node cells and splenocytes from MOG 35-55 immunized mice in response to MOG 35-55 peptide in vitro. The production of 
IL-17A and IFN-γ by Slfn8
−/− cells was reduced compared with WT mice (Fig. 3a-d) . Notably, reduction of cytokine expression by Slfn8 −/− lymph node cells was apparent. Next, we homogenized the lymph nodes and spleens from MOG immunized mice before disease onset and measured levels of IL-6 and IL-1β, which are also involved in EAE development and T h 17 differentiation (17) (18) (19) . In lymph nodes, both IL-6 and IL-1β expression were reduced by deleting Slfn8 (Fig. 4a and b). In contrast, the levels of IL-6 and IL-1β in the spleen were not different between Slfn8 −/− and WT mice ( Fig. 4c and d) .
T-cell responses and cytokine production by macrophages in Slfn8 −/− mice were normal
We examined whether Slfn8 deficiency affects proliferation of T cells in response to TCR stimulation. Although antigen-specific T-cell responses in Slfn8 −/− were decreased (Fig. 3a-d) , CD4 + T cells of Slfn8 −/− mice exhibited normal proliferation in response to anti-CD3/anti-CD28 stimulation (Fig. 5a) . Next, we examined the cytokine production of peritoneal macrophages stimulated with TLR ligands. The levels of IL-6 and TNF-α production in response to TLR ligands, including Pam3CSK4, LPS and R848, were comparable between WT and Slfn8 −/− macrophages (Fig. 5b) −/− and WT mice (Fig. 5d ).
IL-6 expression by CD31 + ECs was decreased by Slfn8 deficiency
We could not detect any defects in immune cells in Slfn8
mice. However, we demonstrated the reduction of cytokine levels in Slfn8 −/− lymph nodes after MOG 35-55 immunization. We therefore next focused on non-hematopoietic cells such as ECs and fibroblastic reticular cells (FRCs). It has been reported that non-hematopoietic cells including ECs and fibroblasts are involved in the development of autoimmune disease models and inflammatory cytokine production (22, 23) . IL-6 expression in ECs and FRCs has been reported to be higher than in immune cells (24) . We therefore examined whether Slfn8 influenced the function of non-hematopoietic ECs and FRCs in the development of EAE. We isolated lymphatic immune cells and CD45 − CD31 + ECs and CD45 − CD31 − gp38 + FRCs from MOG immunized mice (EAE) or non-immunized mice (B6) by FACS following the pictured gating strategies (Fig. 6a ). We then measured the level of il6 mRNA in isolated cells by qPCR. Interestingly, the basal level of il6 was relatively high in ECs and FRCs. We also confirmed that MOG immunization induced il6 mRNA expression in ECs and FRCs.
To examine whether Slfn8 is involved in il6 mRNA induction in ECs, we analyzed il6 mRNA levels in ECs and FRCs isolated from MOG immunized Slfn8 −/− or WT mice. il6 mRNA levels in Slfn8 −/− FRCs were slightly reduced, while il6 mRNA levels of Slfn8 −/− ECs were significantly reduced ( Fig. 7a and b) . To examine whether Slfn8-deficient non-hematopoietic cells affect activation of MOG-specific T cells in immunized mice, we generated BM chimeric mice. We analyzed the production of IL-17A and IFN-γ in draining lymph node cells from MOG 35-55 immunized chimeric mice in response to MOG peptide. The production of IL-17A and IFN-γ by irradiated WT recipient mice transplanted with either WT or Slfn8 −/− BM (WT → WT and Slfn8 −/− → WT mice, respectively) was not different. The production of IL-17A and IFN-γ by irradiated Slfn8 −/− recipient mice transplanted with WT BM (WT →Slfn8 −/− mice) was significantly reduced compared with irradiated WT recipient mice transplanted with WT BM (WT → WT mice) ( Fig. 7c and d) . These data suggest that Slfn8 deficiency may have influenced the development EAE by regulating inflammation in non-hematopoietic cells.
Discussion
Here, we have shown that the development of EAE was attenuated and IL-6 expression by ECs was impaired by Slfn8 deficiency in mice. Slfn8 is one of several Slfn family member proteins. It has been reported that the SLFN protein family are involved in cell proliferation and growth (5, 6, 8) . However, the physiological function of Slfn8 remains unclear. While we observed attenuation of MOG-induced EAE in Slfn8 −/− mice, no significant differences between WT mice and other Slfn family member-deficient mice (Slfn1, Slfn3 and Slfn5, respectively) with respect to EAE were observed. Among these Slfn family member, Slfn8 and Slfn5, but not Slfn1 and Slfn3, belong to the group III long type Slfn subfamily (1). Although both Slfn8 and Slfn5 harbor similar characteristic domains such as a helicase-like domain, our data clearly showed that only slfn8 is involved in development of EAE. Given that the slight difference in three-dimensional structure or the difference in localization between Slfn8 and Slfn5 may be involved in EAE, further studies are required to clarify how only Slfn8 regulates EAE development. Thus, only Slfn8 seems to be involved in MOG-induced EAE. Although the mechanisms of onset and development of MOG-induced EAE are complicated, in several previous reports using KO mice and neutralizing antibodies, pro-inflammatory cytokines such as IL-6 and IL-17A were shown to be key regulators that participate in the development of EAE (17, 18, 25) . We demonstrated that the production of the T h 17 cytokine IL-17A and the T h 1 cytokine IFN-γ in response to MOG 35-55 peptide was significantly impaired in immunized mice by Slfn8 deletion. This result implies that Slfn8 might be involved in priming antigen-specific T cells. We hypothesized that Slfn8 might also be involved in the function of T cells. However, our results showed no significant differences between WT and Slfn8 −/− T cell proliferation in response to anti-CD3/anti-CD28 antibody. T-cell populations in Slfn8 −/− mice were also comparable between WT and Slfn8 −/− mice. These results indicate that Slfn8 may not have contributed directly to activation and proliferation of antigen-specific T cells. A previous study reported that T-cell development in Slfn8 transgenic thymus was impaired and proliferation of Slfn8 transgenic T cells in response to anti-CD3/anti-CD28 antibody was reduced (1) . In that report, the expression of Slfn8 appears to be decreased by TCR stimulation. This discrepancy may be caused by differences between using transgenic and knockout mice. Thus, further analysis of the role of Slfn8 in T-cell function is required.
We investigated whether deficiency of Slfn8 affected the function of immune cells other than T cells. However, dysfunction of cytokine production in macrophages in response to TLR ligands and abnormal populations of immune cells including macrophages, monocytes, eosinophils and neutrophils after the deletion of Slfn8 were not observed. Although we do not fully examine the function of Slfn8 in immune cells, these investigations suggest that Slfn8 may not have affected the function of immune cells directly.
Therefore, we then focused on non-hematopoietic cells such as ECs and FRCs. It has been reported that the close interaction of non-hematopoietic cells and immune cells plays an important role in autoimmunity (26, 27) . IL-6 expression in non-hematopoietic cells has been suggested to occur in autoimmune disease (22) . It has been reported that blockade of the IL-6 loop significantly suppresses the development of EAE (22) . IL-6 is also known to play a critical role in priming T h 17 cells in vitro. We showed that IL-6 mRNA level in ECs and FRCs was enhanced by MOG immunization. We further showed that the IL-6 mRNA level in Slfn8 −/− ECs was significantly reduced. We found that the production of IL-17A by irradiated Slfn8 −/− recipient mice transplanted with WT BM was significantly reduced compared with irradiated WT recipient mice transplanted with WT BM. These results indicate that Slfn8 may have contributed to the development of EAE via IL-6 production by ECs. To elucidate the molecular mechanism for IL-6 production via Slfn8, we performed yeast two hybrid systems to identify association molecules of this gene. We also found that Slfn8 was associated with some mRNA modification enzymes such as uridylation (data not shown). The data implied that Slfn8 regulates target mRNA by utilizing the uridylation system.
We demonstrated that Slfn8 −/− mice were resistant to the development of EAE. As a human homolog of murine Slfn8
has not yet been detected, further research is required in this area. Although the mechanism controlling inflammation in ECs remains to be fully elucidated, our investigation suggests that Slfn8 is involved in immune responses via the regulation of ECs. This study is therefore helpful for both understanding the function of Slfn8 and further determining the role of nonhematopoietic cells in the immune system. 
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